A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Li, Wei ^a,b   Zhu, Shu ^a,b   Li, Jianhua ^a   Huang, Yan ^a,c   Zhou, Rongrong ^a,c   Fan, Xuegong ^c   Yang, Huan ^a   Gong, Xing ^d   Eissa, N Tony ^d   Jahnen Dechent, Willi ^e   Wang, Ping ^a   Tracey, Kevin J ^a   Sama, Andrew E ^a,b   Wang, Haichao ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; FETUIN A; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; LIVER PROTEIN; ACUTE PHASE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; KNOCKOUT MOUSE; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; SEPSIS; SURVIVAL RATE; WILD TYPE; ANIMAL; CELL LINE; CYTOPLASM; DISEASE PREDISPOSITION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; LIVER; MACROPHAGE; METABOLISM; PATHOLOGY; SECRETION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME;

ANIMALIA; MURINAE; MUS;

ACUTE-PHASE PROTEINS; ALPHA-2-HS-GLYCOPROTEIN; ANIMALS; CELL LINE; CYTOKINES; CYTOPLASM; DISEASE SUSCEPTIBILITY; ENDOTOXEMIA; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; HMGB1 PROTEIN; LIVER; MACROPHAGES; MALE; MICE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS;

EID: 79951559422     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016945     Document Type: Article

References (57)

1. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, et al. (1999) Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285: 732-736.
2. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
3. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
4. Krieg AM, (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20: 709-760.
5. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251.
6. Ivanov S, Dragoi AM, Wang X, Dallacosta C, Louten J, et al. (2007) A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 110: 1970-1981.
7. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, et al. (2000) High Mobility Group 1 Protein (HMG-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes. J Exp Med 192: 565-570.
8. Chen GY, Tang J, Zheng P, Liu Y, (2009) CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323: 1722-1725.
9. Akira S, Takeda K, (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511.
10. Wang H, Ward MF, Sama AE, (2009) Novel HMGB1-inhibiting therapeutic agents for experimental sepsis. Shock 32: 348-357.
11. Ao L, Zou N, Cleveland JC Jr, Fullerton DA, Meng X, (2009) Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70. Am J Physiol Heart Circ Physiol 297: H21-H28.
12. Su X, Ao L, Zou N, Song Y, Yang X, et al. (2008) Post-transcriptional regulation of TNF-induced expression of ICAM-1 and IL-8 in human lung microvascular endothelial cells: an obligatory role for the p38 MAPK-MK2 pathway dissociated with HSP27. Biochim Biophys Acta 1783: 1623-1631.
13. Wang H, Zhu S, Zhou R, Li W, Sama AE, (2008) Therapeutic potential of HMGB1-targeting agents in sepsis. Expert Rev Mol Med 10: e32.
14. Zhu S, Ashok M, Li J, Li W, Yang H, et al. (2009) Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers. Mol Med 15: 275-282.
15. Fan J, Li Y, Levy RM, Fan JJ, Hackam DJ, et al. (2007) Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J Immunol 178: 6573-6580.
16. Li Y, Xiang M, Yuan Y, Xiao G, Zhang J, et al. (2009) Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2. Am J Physiol Regul Integr Comp Physiol 297: R1670-R1680.
17. Yang H, Ochani M, Li J, Qiang X, Tanovic M, et al. (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 101: 296-301.
18. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, et al. (2002) Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A 99: 12351-12356.
19. Chen G, Li J, Qiang X, Czura CJ, Ochani M, et al. (2005) Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis. J Lipid Res 46: 623-627.
20. Li W, Li J, Ashok M, Wu R, Chen D, et al. (2007) A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1. J Immunol 178: 3856-3864.
21. Wang H, Liao H, Ochani M, Justiniani M, Lin X, et al. (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10: 1216-1221.
22. Wang H, Li W, Li J, Rendon-Mitchell B, Ochani M, et al. (2006) The Aqueous Extract of a Popular Herbal Nutrient Supplement, Angelica sinensis, Protects Mice against Lethal Endotoxemia and Sepsis. J Nutr 136: 360-365.
23. Li W, Ashok M, Li J, Yang H, Sama AE, et al. (2007) A Major Ingredient of Green Tea Rescues Mice from Lethal Sepsis Partly by Inhibiting HMGB1. PLoS ONE 2: e1153.
24. Wang H, Czura CJ, Tracey KJ, (2004) Lipid unites disparate syndromes of sepsis. Nat Med 10: 124-125.
25. Christie DL, Dziegielewska KM, Hill RM, Saunders NR, (1987) Fetuin: the bovine homologue of human alpha 2HS glycoprotein. FEBS Lett 214: 45-49.
26. Daveau M, Christian D, Julen N, Hiron M, Arnaud P, et al. (1988) The synthesis of human alpha-2-HS glycoprotein is down-regulated by cytokines in hepatoma HepG2 cells. FEBS Lett 241: 191-194.
27. Dziegielewska KM, Brown WM, (1995) Fetuin. Landes Co., Austin, Texas Springer Verlag pp. 1-178.
28. Ohnishi T, Nakamura O, Ozawa M, Arakaki N, Muramatsu T, et al. (1993) Molecular cloning and sequence analysis of cDNA for a 59 kD bone sialoprotein of the rat: demonstration that it is a counterpart of human alpha 2-HS glycoprotein and bovine fetuin. J Bone Miner Res 8: 367-377.
29. Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, et al. (2008) Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 118: 2555-2562.
30. Tuttolomondo A, Di Raimondo D, Di Sciacca R, Casuccio A, Bivona G, et al. (2010) Fetuin-A and CD40 L plasma levels in acute ischemic stroke: differences in relation to TOAST subtype and correlation with clinical and laboratory variables. Atherosclerosis 208: 290-296.
31. Dziegielewska KM, Brown WM, Gould CC, Matthews N, Sedgwick JE, et al. (1992) Fetuin: an acute phase protein in cattle. J Comp Physiol [B] 162: 168-171.
32. Mathews ST, Srinivas PR, Leon MA, Grunberger G, (1997) Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase. Life Sci 61: 1583-1592.
33. Haasemann M, Nawratil P, Muller-Esterl W, (1991) Rat tyrosine kinase inhibitor shows sequence similarity to human alpha 2-HS glycoprotein and bovine fetuin. Biochem J 274: 899-902.
34. Demetriou M, Binkert C, Sukhu B, Tenenbaum HC, Dennis JW, (1996) Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist. J Biol Chem 271: 12755-12761.
35. Suzuki M, Shimokawa H, Takagi Y, Sasaki S, (1994) Calcium-binding properties of fetuin in fetal bovine serum. The Journal of Experimental Zoology 270: 501-507.
36. Wang H, Zhang M, Soda K, Sama A, Tracey KJ, (1997) Fetuin protects the fetus from TNF [letter]. Lancet 350: 861-862.
37. Schinke T, Amendt C, Trindl A, Poschke O, Muller-Esterl W, et al. (1996) The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem 271: 20789-20796.
38. Szweras M, Liu D, Partridge EA, Pawling J, Sukhu B, et al. (2002) alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem 277: 19991-19997.
39. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, et al. (2003) The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112: 357-366.
40. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, et al. (2003) Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361: 827-833.
41. Dziegielewska KM, Andersen NA, Saunders NR, (1998) Modification of macrophage response to lipopolysaccharide by fetuin. Immunol Lett 60: 31-35.
42. Ombrellino M, Wang H, Yang H, Zhang M, Vishnubhakat J, et al. (2001) Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan. Shock 15: 181-185.
43. Wang H, Li W, Zhu S, Li J, D'Amore J, et al. (2010) Peripheral administration of fetuin-A attenuates early cerebral ischemic injury in rats. J Cereb Blood Flow Metab 30: 493-504.
44. Tang D, Kang R, Xiao W, Zhang H, Lotze MT, et al. (2009) Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function. Am J Respir Cell Mol Biol 41: 651-660.
45. Xu Y, Jagannath C, Liu XD, Sharafkhaneh A, Kolodziejska KE, et al. (2007) Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 27: 135-144.
46. Deriy LV, Beno DW, Uhing MR, Jiyamapa-Serna VA, Kimura RE, (2002) Splenectomy ablates endotoxin-induced IFNgamma response in rats. Shock 17: 312-315.
47. Heinzel FP, (1990) The role of IFN-gamma in the pathology of experimental endotoxemia. J Immunol 145: 2920-2924.
48. Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, et al. (1992) Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. J Immunol 149: 1666-1670.
49. Yin K, Gribbin E, Wang H, (2005) Interferon-gamma inhibition attenuates lethality after cecal ligation and puncture in rats: implication of high mobility group box-1. Shock 24: 396-401.
50. Rendon-Mitchell B, Ochani M, Li J, Han J, Wang H, et al. (2003) IFN-gamma Induces High Mobility Group Box 1 Protein Release Partly Through a TNF-Dependent Mechanism. J Immunol 170: 3890-3897.
51. Chmiela M, Czkwianianc E, Wadstrom T, Rudnicka W, (1997) Role of Helicobacter pylori surface structures in bacterial interaction with macrophages. Gut 40: 20-24.
52. Dubreuil JD, Giudice GD, Rappuoli R, (2002) Helicobacter pylori interactions with host serum and extracellular matrix proteins: potential role in the infectious process. Microbiol Mol Biol Rev 66: 617-29.
53. Lord JM, (2003) A physiological role for alpha2-HS glycoprotein: stimulation of macrophage uptake of apoptotic cells. Clin Sci (Lond) 105: 267-268.
54. Jersmann HP, Dransfield I, Hart SP, (2003) Fetuin/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin Sci (Lond) 105: 273-278.
55. Bell CW, Jiang W, Reich CF, Pisetsky DS, (2006) The Extracellular Release of HMGB1 during Apoptotic Cell Death. Am J Physiol Cell Physiol 291 (6): C1318-1325.
56. Yang S, Zhou M, Chaudry IH, Wang P, (2002) Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: role of adrenomedullin and adrenomedullin binding protein-1. Ann Surg 236: 625-633.
57. Chen G, Li J, Ochani M, Rendon-Mitchell B, Qiang X, et al. (2004) Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J Leukoc Biol 76: 994-1001.